Lactoferrin regulates an axis involving CD11b and CD49d integrins and the chemokines MIP-1α and MCP-1 in GM-CSF-Treated human primary eosinophils

Journal of Interferon and Cytokine Research

Volumn 32, Issue 10, 2012, Pages 450-461

  Curran, Colleen S ^a   Bertics, Paul J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; CALGRANULIN B; CD11B ANTIGEN; EOSINOPHIL PEROXIDASE; FIBRONECTIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LACTOFERRIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ASTHMA; BINDING KINETICS; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

AMINE OXIDASE (COPPER-CONTAINING); ANTIGENS, CD11B; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL3; EOSINOPHILS; FIBRONECTINS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTEGRIN ALPHA4; LACTOFERRIN; PRIMARY CELL CULTURE;

EID: 84867554078     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0111     Document Type: Article

References (64)

1. Abbas M, Lalive PH, Chofflon M, Simon HU, Chizzolini C, Ribi C. 2011. Hypereosinophilia in patients with multiple sclerosis treated with natalizumab. Neurology 77(16):1561-1564.
2. Adamko DJ, Wu Y, Ajamian F, Ilarraza R, Moqbel R, Gleich GJ. 2008. The effect of cationic charge on release of eosinophil mediators. J Allergy Clin Immunol 122(2):383-390, 390 e1-e4.
3. Adamko DJ, Wu Y, Gleich GJ, Lacy P, Moqbel R. 2004. The induction of eosinophil peroxidase release: improved methods of measurement and stimulation. J Immunol Methods 291(1- 2):101-108.
4. Anwar AR, Moqbel R, Walsh GM, Kay AB, Wardlaw AJ. 1993. Adhesion to fibronectin prolongs eosinophil survival. J Exp Med 177(3):839-843.
5. Anwar AR, Walsh GM, Cromwell O, Kay AB, Wardlaw AJ. 1994. Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4). Immunology 82(2):222-228.
6. Ashida K, Sasaki H, Suzuki YA, Lonnerdal B. 2004. Cellular internalization of lactoferrin in intestinal epithelial cells. Biometals 17(3):311-315.
7. Baker HM, Baker EN. 2012. A structural perspective on lactoferrin function. Biochem Cell Biol 90(3):320-328.
8. Barthel SR, Annis DS, Mosher DF, Johansson MW. 2006. Differential engagement of modules 1 and 4 of vascular cell adhesion molecule-1 (CD106) by integrins alpha4beta1 (CD49d/ 29) and alphaMbeta2 (CD11b/18) of eosinophils. J Biol Chem 281(43):32175-32187.
9. Barthel SR, Johansson MW, McNamee DM, Mosher DF. 2008. Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma. J Leukoc Biol 83(1): 1-12.
10. Bates ME, Sedgwick JB, Zhu Y, Liu LY, Heuser RG, Jarjour NN, Kita H, Bertics PJ. 2010. Human airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the Ras- ERK pathway when compared with blood eosinophils. J Immunol 184(12):7125-7133.
11. Bournazou I, Mackenzie KJ, Duffin R, Rossi AG, Gregory CD. 2010. Inhibition of eosinophil migration by lactoferrin. Immunol Cell Biol 88(2):220-223.
12. Brock JH. 2002. The physiology of lactoferrin. Biochem Cell Biol 80(1):1-6.
13. Carr MW, Alon R, Springer TA. 1996. The C-C chemokine MCP- 1 differentially modulates the avidity of beta 1 and beta 2 integrins on T lymphocytes. Immunity 4(2):179-187.
14. Chodaczek G, Saavedra-Molina A, Bacsi A, Kruzel ML, Sur S, Boldogh I. 2007. Iron-mediated dismutation of superoxide anion augments antigen-induced allergic inflammation: Effect of lactoferrin. Postepy Hig Med Dosw (Online) 61: 268-276.
15. Chuang KP, Tsai WS, Wang YJ, Shieh CC. 2003. Superoxide activates very late antigen-4 on an eosinophil cell line and increases cellular binding to vascular cell adhesion molecule- 1. Eur J Immunol 33(3):645-655.
16. Comhair SA, Erzurum SC. 2010. Redox control of asthma: Molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 12(1):93-124.
17. Culley FJ, Fadlon EJ, Kirchem A, Williams TJ, Jose PJ, Pease JE. 2003. Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines. Eur J Immunol 33(5): 1302-1310.
18. Curran CS, Bertics PJ. 2011. Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B. Int Immunol 23(12):713-728.
19. Curran CS, Evans MD, Bertics PJ. 2011. GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation. J Immunol 187(3):1254-1263.
20. Feistritzer C, Kaneider NC, Sturn DH, Wiedermann CJ. 2004. Syndecan-4-dependent migration of human eosinophils. Clin Exp Allergy 34(5):696-703.
21. Garmy-Susini B, Avraamides CJ, Schmid MC, Foubert P, Ellies LG, Barnes L, Feral C, Papayannopoulou T, Lowy A, Blair SL, et al. 2010. Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis. Cancer Res 70(8): 3042-3051.
22. Harmsen MC, Swart PJ, de Bethune MP, Pauwels R, De Clercq E, The TH, Meijer DK. 1995. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis 172(2):380-388.
23. Jeziorska M, Haboubi N, Schofield P, Woolley DE. 2001. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique. J Pathol 194(4):484-492.
24. Jiang R, Lonnerdal B. 2012. Apo- and holo-lactoferrin stimulate proliferation of mouse crypt cells but through different cellular signaling pathways. Int J Biochem Cell Biol 44(1):91-100.
25. Jiang R, Lopez V, Kelleher SL, Lonnerdal B. 2011. Apo- and hololactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERKsignaling and cell proliferation in Caco-2 cells. J Cell Physiol 226(11):3022-3031.
26. Johansson S, Svineng G, Wennerberg K, Armulik A, Lohikangas L. 1997. Fibronectin-integrin interactions. Front Biosci 2:d126- d146.
27. Kayaba H, Yamada Y, Cui CH, Saito N, Honda K, Kobayashi Y, Urayama O, Chihara J. 2001. Expression of VLA-4 on eosinophils decreases in patients with eosinophilia. Int Arch Allergy Immunol 125 Suppl 1:33-37.
28. Kayazawa M, Saitoh O, Kojima K, Nakagawa K, Tanaka S, Tabata K, Matsuse R, Uchida K, Hoshimoto M, Hirata I et al. 2002. Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: Comparison with other neutrophil-derived proteins. Am J Gastroenterol 97(2):360-369.
29. Kita H. 2011. Eosinophils: Multifaceted biological properties and roles in health and disease. Immunol Rev 242(1):161- 177.
30. Klebanoff SJ, Waltersdorph AM. 1990. Prooxidant activity of transferrin and lactoferrin. J Exp Med 172(5):1293-1303.
31. Kruzel ML, Bacsi A, Choudhury B, Sur S, Boldogh I. 2006. Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma. Immunology 119(2):159-166.
32. Kuwata H, Yip TT, Yip CL, Tomita M, Hutchens TW. 1998. Direct detection and quantitative determination of bovine lactoferricin and lactoferrin fragments in human gastric contents by affinity mass spectrometry. Adv Exp Med Biol 443:23-32.
33. Lampinen M, Carlson M, Hakansson LD, Venge P. 2004. Cytokine- regulated accumulation of eosinophils in inflammatory disease. Allergy 59(8):793-805.
34. Legrand D, Mazurier J. 2010. A critical review of the roles of host lactoferrin in immunity. Biometals 23(3):365-376.
35. Li D, Sakashita S, Morishita Y, Kano J, Shiba A, Sato T, Noguchi M. 2011. Binding of lactoferrin to IGBP1 triggers apoptosis in a lung adenocarcinoma cell line. Anticancer Res 31(2): 529-534.
36. Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, Gunzer M, Frings W, Schonlau F, Roth J, Sorg C, et al. 2003. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol 23(3):1034-1043.
37. Matsumoto K, Sterbinsky SA, Bickel CA, Zhou DF, Kovach NL, Bochner BS. 1997. Regulation of alpha 4 integrin-mediated adhesion of human eosinophils to fibronectin and vascular cell adhesion molecule-1. J Allergy Clin Immunol 99(5): 648-656.
38. Monteseirin J. 2009. Neutrophils and asthma. J Investig Allergol Clin Immunol 19(5):340-354.
39. Nadolska B, Fraczek M, Krecicki T, Kocieba M, Zimecki M. 2010. Lactoferrin inhibits the growth of nasal polyp fibroblasts. Pharmacol Rep 62(6):1139-1147.
40. Nagata M, Yamamoto H, Shibasaki M, Sakamoto Y, Matsuo H. 2000. Hydrogen peroxide augments eosinophil adhesion via beta2 integrin. Immunology 101(3):412-418.
41. Naot D, Chhana A, Matthews BG, Callon KE, Tong PC, Lin JM, Costa JL, Watson M, Grey AB, Cornish J. 2011. Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts. Bone 49(2):217-224.
42. Newton RA, Hogg N. 1998. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 160(3):1427-1435.
43. Puig-Kroger A, Sanz-Rodriguez F, Longo N, Sanchez-Mateos P, Botella L, Teixido J, Bernabeu C, Corbi AL. 2000. Maturationdependent expression and function of the CD49d integrin on monocyte-derived human dendritic cells. J Immunol 165(8): 4338-4345.
44. Ross GD. 2002. Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion. Immunol Res 25(3):219-227.
45. Sakamoto K, Ito Y, Mori T, Sugimura K. 2006. Interaction of human lactoferrin with cell adhesion molecules through RGD motif elucidated by lactoferrin-binding epitopes. J Biol Chem 281(34):24472-24478.
46. Samoszuk M. 1997. Eosinophils and human cancer. Histol Histopathol 12(3):807-812.
47. Sampson AP. 2000. The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy 30 Suppl 1:22-27.
48. Sandomirsky BP, Galchenko SE, Galchenko KS. 2003. Antioxidative properties of lactoferrin from bovine colostrum before and after its lyophilization. Cryo Lett 24(5): 275-280.
49. Shimazaki K, Tazume T, Uji K, Tanaka M, Kumura H, Mikawa K, Shimo-Oka T. 1998. Properties of a heparin-binding peptide derived from bovine lactoferrin. J Dairy Sci 81(11):2841- 2849.
50. Simon D, Wardlaw A, Rothenberg ME. 2010. Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. J Allergy Clin Immunol 126(1):3-13; quiz 14-15.
51. Singh J, Adams S, Carter MB, Cuervo H, Lee WC, Lobb RR, Pepinsky RB, Petter R, Scott D. 2004. Rational design of potent and selective VLA-4 inhibitors and their utility in the treatment of asthma. Curr Top Med Chem 4(14):1497-1507.
52. Skarica M, Eckstein C, Whartenby KA, Calabresi PA. 2011. Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients. J Neuroimmunol 235(1-2):70-76.
53. Spik G, Legrand D, Leveugle B, Mazurier J, Mikogami T, Montreuil J, Pierce A, Rochard E. 1994. Characterization of two kinds of lactotransferrin (lactoferrin) receptors on different target cells. Adv Exp Med Biol 357:13-19.
54. Strath M, Warren DJ, Sanderson CJ. 1985. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J Immunol Methods 83(2):209-215.
55. Suzuki YA, Lopez V, Lonnerdal B. 2005. Mammalian lactoferrin receptors: Structure and function. Cellular and molecular life sciences: CMLS 62(22):2560-2575.
56. Tachimoto H, Ebisawa M, Bochner BS. 2002. Cross-talk between integrins and chemokines that influences eosinophil adhesion and migration. Int Arch Allergy Immunol 128 Suppl 1:18-20.
57. Travis SM, Conway BA, Zabner J, Smith JJ, Anderson NN, Singh PK, Greenberg EP, Welsh MJ. 1999. Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol 20(5):872-879.
58. van Berkel PH, Geerts ME, van Veen HA, Mericskay M, de Boer HA, Nuijens JH. 1997. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem J 328 (Pt 1):145-151.
59. Vogel HJ, Schibli DJ, Jing W, Lohmeier-Vogel EM, Epand RF, Epand RM. 2002. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and argininecontaining peptides. Biochem Cell Biol 80(1):49-63.
60. Walsh GM, Symon FA, Lazarovils AL, Wardlaw AJ. 1996. Integrin alpha 4 beta 7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin. Immunology 89(1):112-119.
61. Ward PP, Paz E, Conneely OM. 2005. Multifunctional roles of lactoferrin: A critical overview. Cell Mol Life Sci 62(22): 2540-2548.
62. Weber C, Alon R, Moser B, Springer TA. 1996. Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis. J Cell Biol 134(4):1063-1073.
63. Wong CK, Ip WK, Lam CW. 2003. Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor-induced adhesion molecule expression on eosinophils by p38 mitogenactivated protein kinase and nuclear factor-[kappa] B. Am J Respir Cell Mol Biol 29(1):133-147.
64. Woodruff SA, Masterson JC, Fillon S, Robinson ZD, Furuta GT. 2011. Role of eosinophils in inflammatory bowel and gastrointestinal diseases. J Pediatr Gastroenterol Nutr 52(6):650-661.